• Carretero M, Guerrero-Aspizua S, Illera N, Galvez V, Navarro M, García-García F, Dopazo J, Jorcano JL, Larcher F, Del Rio M. Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models. J Invest Dermatol. 2016;136(1):136-45.

• Chamorro C, Mencía A, Almarza D, Duarte B, Büning H, Sallach J, Hausser I, Del Río M, Larcher F, Murillas R. Gene Editing for the Efficient Correction of a Recurrent COL7A1 Mutation in Recessive Dystrophic Epidermolysis Bullosa Keratinocytes. Mol Ther Nucleic Acids. 2016 Apr 5;5:e307. 

• Martín-Mateos P, Dornuf F, Duarte B, Hils B, Moreno-Oyervides A, Bonilla-Manrique OE, Larcher F, Krozer V, Acedo P. In-vivo, non-invasive detection of hyperglycemic states in animal models using mm-wave spectroscopy. Sci Rep. 2016 Sep 27; 6:34035. doi: 10.1038/srep34035.

• Zhou D, Cutlar L, Gao Y, Wang W, O'Keeffe-Ahern J, McMahon S, Duarte B, Larcher F, Rodriguez BJ, Greiser U, Wang W. The transition from linear to highly branched poly(β-amino ester)s: Branching matters for gene delivery. Sci Adv. 2016 Jun 17;2(6):e1600102

• Cutlar L, Zhou D, Hu X, Duarte B, Greiser U, Larcher F, Wang W. A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa. Exp Dermatol. 2016 Oct;25(10):818-20. 

• Luchetti MM, Moroncini G, Jose Escamez M, Svegliati Baroni S, Spadoni T, Grieco A, Paolini C, Funaro A, Avvedimento EV, Larcher F, Del Rio M, Gabrielli A. Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti-Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies. Arthritis Rheumatol. 2016;68(9):2263-73.

• Mencía Á, García M, García E, Llames S, Charlesworth A, de Lucas R, Vicente A, Trujillo-Tiebas MJ, Coto P, Costa M, Vera Á, López-Pestaña A, Murillas R, Meneguzzi G, Jorcano JL, Conti CJ, Escámez Toledano MJ, del Río Nechaevsky M. Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia. Exp Dermatol. 2016 Apr;25(4):269-74. doi: 10.1111/exd.12938.

• García M, Quintana-Bustamante O, Segovia JC, Bueren J, Martinez-Santamaría L, Guerrero-Aspizua S, Escamez MJ, Del Rio M, Larcher F. Long-term skin regeneration in xenografts from iPSC teratoma-derived human keratinocytes. Exp Dermatol. 2016 Sep;25(9):736-8.

• Puig-Butille JA, Gimenez-Xavier P, Visconti A, Nsengimana J, Garcia-García F,  Tell-Marti G, Escamez MJ, Newton-Bishop J, Bataille V, Del Río M, Dopazo J, Falchi M, Puig S. Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatics analysis. Oncotarget. 2017 Feb 14;8(7):11589-11599. doi: 10.18632/oncotarget.14140. 

• Valdés A, Cifuentes A, León C. Foodomics evaluation of bioactive compounds in foods. Trends in Anal Chem. 2017; 96: 2-13. doi: 10.1016/j.trac.2017.06.004.

• Latella MC, Cocchiarella F, De Rosa L, Turchiano G, Gonçalves MA, Larcher F, De Luca M, Recchia A. Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. J Invest Dermatol. 2017;137(4):836-44.

• Zamarrón A, Garcia M, Del Río M, Larcher F, Juarranz A. Combined effect of UV light and MAL-PDT in dermal fibroblasts from Xeroderma Pigmentosum and Gorlin-goltz syndrome patients. 2017 Oncotarget; 8(44): 77385–77399. (Acceder a la publicación).

• Peking P, Koller U, Duarte B, Murillas R, Wolf S, Maetzig T, Rothe M, Kocher T, García M, Brachtl G, Schambach A, Larcher F, Reichelt J, Bauer JW, Murauer EM. An RNA-targeted therapy for dystrophic epidermolysis bullosa. Nucleic Acids Res. 2017; 45(17):10259-10269. 

• Hainzl S, Peking P, Kocher T, Murauer EM, Larcher F, Del Rio M, Duarte B, Steiner M, Klausegger A, Bauer JW, Reichelt J, Koller U. COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa. Mol Ther. 2017. pii: S1525-0016(17)30319-2.

• Dornuf F, Martín-Mateos P, Duarte B, Hils B, Bonilla-Manrique OE, Larcher F, Acedo P, Krozer V. Classification of skin phenotypes caused by diabetes mellitus  using complex scattering parameters in the millimeter-wave frequency range. Sci Rep. 2017; 7(1):5822.

• Knöpfel N, Noguera-Morel L, Hernández-Martin A, García-Martin A, García M, Mencía Á, Pedrero RM, de Lucas R, Escámez MJ, Torrelo A. Identical COL71A1 heterozygous mutations resulting in different dystrophic epidermolysis bullosa phenotypes. Pediatr Dermatol. 2018 Mar;35(2):e94-e98. doi: 10.1111/pde.13367.

• Sánchez-Jimeno C, Escámez MJ, Ayuso C, Trujillo-Tiebas MJ, Del Río M Genetic diagnosis of epidermolysis bullosa: recommendations from an expert Spanish research group. Actas Dermosifiliogr. 2018 Mar;109(2):104-122. doi: 10.1016/j.ad.2017.08.008.

• Mencia A, Chamorro C, Bonafont J, Duarte B, Holguin A, Illera N, Escamez MJ, Hauser I, Del Río M, Larcher F, Murillas R. Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells. Mol Ther Nucleic Acids. 2018. 11, 2018, 68-78.

• Chacón-Solano E, León C, Díaz F, García-García F, García M, Escámez MJ, Guerrero-Aspizua S, Conti CJ, Mencía Á, Martínez-Santamaría L, Llames S, Pévida M, Carbonell-Caballero J, Puig-Butillé JA, Maseda R, Puig S, de Lucas R, Baselga  E, Larcher F, Dopazo J, Del Río M. Fibroblasts activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses. Br J Dermatol. 2019 Jan 28. doi: 10.1111/bjd.17698.